-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Maintains Speculative Buy on CapsoVision, Lowers Price Target to $10

Benzinga·03/27/2026 15:23:01
Listen to the news
Benchmark analyst Bruce Jackson maintains CapsoVision (NASDAQ:CV) with a Speculative Buy and lowers the price target from $14 to $10.